9MY-62974-52615
5 vaccinations
5 coded responses
46 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 537 / WI
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Registered in v-safe
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-01-25
Survey response — day 0, dose 1MedDRA: No adverse event, Unevaluable event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-08
- 2021-02-15
-
2021-02-16
Dose 2 — Pfizer-BioNTech
- 2021-02-17
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
-
2021-03-02
Survey response — day 14, dose 2MedDRA: Dizziness, Myalgia — Feeling: GoodFree text: Mild general muscle achesMild dizziness Both more pronounced upon wake up, faded afterHas lasted for about 3 days so farMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — day 21, dose 2MedDRA: Asthma, Hypersensitivity, Pre-existing disease, Self-medication, Urticaria — Feeling: GoodFree text: Middle of the night had a mild allergy attack - general small hives, mild asthma. Used ventolin inhaler, took a 25 mg Benadryl. All gone in abt 2 hrs. Have a history of allergies and mild asthma, had no known trigger for the attack. The vaccine?????MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-05-18
- 2021-08-17
-
2021-10-13
Dose 3 — Pfizer-BioNTech
- 2022-02-16
-
2022-04-15
Dose 4 — Pfizer-BioNTech
-
2022-04-22
Survey response — day 7, dose 4MedDRA: Injection site pain — Feeling: GoodFree text: Sore muscle at the shot site through 1 day afterMedDRA releases: 2024-11 · check-in free text available
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-05-27
- 2022-07-15
-
2022-09-21
Dose 5 — Pfizer-BioNTech
-
2022-09-22
Survey response — days 1–6 daily, dose 5MedDRA: Insomnia — Feeling: Good · Site: PainFree text: Some insomnia last nightMedDRA releases: 2024-11 · check-in free text available
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-10-13 | Pfizer-BioNTech | No |
| 4 | 2022-04-15 | Pfizer-BioNTech | No |
| 5 | 2022-09-21 | Pfizer-BioNTech | No |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): No
Release 4 — day 14, dose 2
Symptoms: Mild general muscle achesMild dizziness Both more pronounced upon wake up, faded afterHas lasted for about 3 days so far
Release 5 — day 21, dose 2
Symptoms: Middle of the night had a mild allergy attack - general small hives, mild asthma. Used ventolin inhaler, took a 25 mg Benadryl. All gone in abt 2 hrs. Have a history of allergies and mild asthma, had no known trigger for the attack. The vaccine????? cut off by CDC
Release 11 — day 7, dose 4
Systemic reaction (other): Sore muscle at the shot site through 1 day after
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Some insomnia last night
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release